Literature DB >> 6132449

N-acetylcysteine prevents the doxorubicin-induced decrease of cyclic GMP.

D V Unverferth, R H Fertel, S P Balcerzak, R D Magorien, M S O'Dorisio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132449

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  5 in total

Review 1.  Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors:  V B Pai; M C Nahata
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

Review 2.  Clinical pharmacokinetics of N-acetylcysteine.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

Review 3.  Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity.

Authors:  Folefac Aminkeng; Colin J D Ross; Shahrad R Rassekh; Soomi Hwang; Michael J Rieder; Amit P Bhavsar; Anne Smith; Shubhayan Sanatani; Karen A Gelmon; Daniel Bernstein; Michael R Hayden; Ursula Amstutz; Bruce C Carleton
Journal:  Br J Clin Pharmacol       Date:  2016-06-30       Impact factor: 4.335

4.  Micromethods for determining activities of energy-producing and non-energy-producing pathways in myocardial tissue.

Authors:  J W King; F S Kennedy; H G Hanley; J J Lierl; M R Fowler; M C White
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

Review 5.  Cardioprotective interventions for cancer patients receiving anthracyclines.

Authors:  Elvira C van Dalen; Huib N Caron; Heather O Dickinson; Leontien Cm Kremer
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.